More bronchiectasis patients benefit from macrolides

Current European guidelines should not be seen as ‘strict rules’, study suggests

Long-term use of macrolides for bronchiectasis can reduce and delay exacerbations and improve quality of life even in patients currently excluded in guidelines, a meta-analysis shows.

White pill

Data for individual participants in three high-quality randomised controlled trials comparing at least three months of a macrolide use with placebo was reanalysed – effectively making a larger randomised controlled trial with 341 participants.

One of the studies included was the Australian BLESS trial of erythromycin vs placebo. The other two trials, including one from New

Latest

Trending